Knowledge Exchange by ISID

AMR Challenges: An MIS-C COVID-19 Patient in a LMIC
Chair(s):
Esmita Charani
,
Esmita Charani
Affiliations:
Seif Al-Abri
Seif Al-Abri
Affiliations:
Speaker(s):
Shirani Chandrasiri
,
Shirani Chandrasiri
Affiliations:
Duminda Samarasinghe
Duminda Samarasinghe
Affiliations:
Knowledge Exchange. Faculty / Presenters . 06/21/22; 356830 Disclosure(s):
 
Esmita Charani
Seif Al-Abri
Shirani Chandrasiri
Duminda Samarasinghe
About this activity
AMR Challenges: An MIS-C COVID-19 Patient in a LMIC
This webinar is in Open Access and was hosted on Tuesday, the 21st of June 2022 from 8:00 - 9:00 EDT

Faculty:

Shirani Chandrasiri, Sri Lanka
Esmita Charani, UK
Duminda Samsrasinghe, Sri Lanka
Seif Al-Abri, Oman

*This webinar is supported with an Unrestricted Educational Grant from bioMérieux.

Objectives:
This session will review some of the AMR challenges faced in low and middle income countries. AMR is a growing problem globally. The increase in resistance of microbes to antimicrobials is outpaced by the development of effective and safe antimicrobial agents. AMR has both health and economic impacts particularly in low and middle income countries. In low resource settings, there is low availability and high costs of some of the laboratory tests routinely conducted in high income countries to manage AMR. This grand round presentation is a clinical case presentation of an infectious disease with eventful progression in a middle income country.
 
References
1. S. Gandra, G. Alvarez-Uria, P. Turner, J. Joshi, D. Limmathurotsakul, H.R. van Doorn. Antimicrobial resistance surveillance in low-and middle-income countries: progress and challenges in eight South Asian and Southeast Asian countries Clin Microbiol Rev, 33 (2020), pp. 1-29
2. Wellcome (2020). The Global Response to AMR: Momentum, success, and critical gaps. https://cms.wellcome.org/sites/default/files/2020-11/wellcome-global-response-amr-report.pdf
 
Discussion questions:

1. Considering AMR is a growing global health concern. What are the major challenges in AMR faced by low and middle income countries?
2. What laboratory capacities are required to reduce the burden of AMR in this setting?
3. The case presentation highlights some of the challenges faced in the management of Infectious diseases. What could have been done better in the management of this case? Taking into account the limitations encountered?

Evaluation Form linkhttps://isid.typeform.com/to/f2yUIB06

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies